Literature DB >> 15238776

Effect of discontinuing antiretroviral therapy on survival of women initiated on highly active antiretroviral therapy.

Yolanda Barrón1, Stephen R Cole, Ruth M Greenblatt, Mardge H Cohen, Kathryn Anastos, Jack A DeHovitz, Robert Delapenha, Stephen J Gange.   

Abstract

OBJECTIVE: To estimate the effect of discontinuing antiretroviral therapy (ART) on survival, among women who initiated highly active antiretroviral therapy (HAART).
DESIGN: A multicenter cohort study.
METHODS: A total of 951 HAART-initiated women were followed for total mortality between 1995 and 2002. The relative hazard (RH) of death attributable to discontinuing all ART was estimated using an inverse probability of treatment-weighted marginal structural Cox proportional hazards model, as well as standard Cox models.
RESULTS: Three hundred and forty-three out of 951 women discontinued all ART during the 3187 person-years of follow-up, and 116 died. The RH of death attributable to discontinuation was 1.97 [95% confidence interval (CI) 1.17, 3.31] from the marginal structural Cox model. A RH of 1.49 (95% CI 0.94, 2.35) was observed using the same set of covariates in a standard Cox model.
CONCLUSION: An increased risk of mortality for those HAART initiators who discontinued ART was observed using a marginal structural Cox model. This increased risk was independent of measured treatment failure, and was greatly attenuated in a standard Cox model with time-varying covariates.

Entities:  

Mesh:

Year:  2004        PMID: 15238776     DOI: 10.1097/01.aids.0000131359.37210.1f

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  8 in total

1.  Association of Risk of Viremia, Immunosuppression, Serious Clinical Events, and Mortality With Increasing Age in Perinatally Human Immunodeficiency Virus-Infected Youth.

Authors:  Anne M Neilan; Brad Karalius; Kunjal Patel; Russell B Van Dyke; Mark J Abzug; Allison L Agwu; Paige L Williams; Murli Purswani; Deborah Kacanek; James M Oleske; Sandra K Burchett; Andrew Wiznia; Miriam Chernoff; George R Seage; Andrea L Ciaranello
Journal:  JAMA Pediatr       Date:  2017-05-01       Impact factor: 16.193

2.  A simulation study of finite-sample properties of marginal structural Cox proportional hazards models.

Authors:  Daniel Westreich; Stephen R Cole; Enrique F Schisterman; Robert W Platt
Journal:  Stat Med       Date:  2012-04-11       Impact factor: 2.373

3.  Time scale and adjusted survival curves for marginal structural cox models.

Authors:  Daniel Westreich; Stephen R Cole; Phyllis C Tien; Joan S Chmiel; Lawrence Kingsley; Michele Jonsson Funk; Kathryn Anastos; Lisa P Jacobson
Journal:  Am J Epidemiol       Date:  2010-02-05       Impact factor: 4.897

4.  Discontinuation of antiretroviral therapy among adults receiving HIV care in the United States.

Authors:  Alison J Hughes; Christine L Mattson; Susan Scheer; Linda Beer; Jacek Skarbinski
Journal:  J Acquir Immune Defic Syndr       Date:  2014-05-01       Impact factor: 3.731

5.  Constructing inverse probability weights for marginal structural models.

Authors:  Stephen R Cole; Miguel A Hernán
Journal:  Am J Epidemiol       Date:  2008-08-05       Impact factor: 4.897

6.  The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Côte d'Ivoire.

Authors:  Elena Losina; Yazdan Yazdanpanah; Sylvie Deuffic-Burban; Bingxia Wang; Lindsey L Wolf; Eugène Messou; Delphine Gabillard; Catherine Seyler; Kenneth A Freedberg; Xavier Anglaret
Journal:  Antivir Ther       Date:  2007

7.  Injection drug use and patterns of highly active antiretroviral therapy use: an analysis of ALIVE, WIHS, and MACS cohorts.

Authors:  John D Morris; Elizabeth T Golub; Shruti H Mehta; Lisa P Jacobson; Stephen J Gange
Journal:  AIDS Res Ther       Date:  2007-06-06       Impact factor: 2.250

8.  State variation in HIV/AIDS health outcomes: the effect of spending on social services and public health.

Authors:  Kristina M Talbert-Slagle; Maureen E Canavan; Erika M Rogan; Leslie A Curry; Elizabeth H Bradley
Journal:  AIDS       Date:  2016-02-20       Impact factor: 4.177

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.